China · Series E startup

Who invested in Yaoshibang

2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

B2BBiotechHealthcare

Valuation: $1.0B, Apr 2022

Funding summaryUpdated 26 Oct 2026

$403Mraised across 2 rounds since 2018, from 2 sources

$133MRound$270MSeries E
Latest round
Series E, $270MJun 2021
Step-upi
2×
Investors
4
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201920202021
$133MRound$270MSeries E
First round
Round, $133M
Dec 2018
Biggest round
$270M
Series E · Jun 2021
Between rounds
2.5 years
from the last two

The rounds

  1. Jun 2021
  2. Dec 2018

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

DCM VenturesPrivate equity2rounds
Shunwei CapitalVC firm1round
Green Pine CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Yaoshibang

Who invested in Yaoshibang?

Yaoshibang's investors include Tiger Global Management, DCM Ventures, Shunwei Capital and Green Pine Capital.

How much has Yaoshibang raised?

Yaoshibang has raised $403M across 2 rounds since 2018.

When did Yaoshibang last raise?

Yaoshibang's most recent round was a Series E of $270M in Jun 2021.

What was Yaoshibang's biggest round?

Its most recent round, $270M in Jun 2021, is also its largest on record.

Who backed Yaoshibang first?

Yaoshibang's first round on record, in Dec 2018, was backed by Tiger Global Management and DCM Ventures.

What stage is Yaoshibang at?

Yaoshibang's latest named round is a Series E, in Jun 2021.

Where is Yaoshibang based?

Yaoshibang is based in China.

Companies like Yaoshibang

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.